|
|
|
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA
|
FOR IMMEDIATE RELEASE |
Media Inquiries: 301-827-6242 |
On Friday, November 21, 2003, the 10th Circuit Court of Appeals decision, which denied a motion from RxDepot to stay the District Court’s ruling, pending appeal, sent yet another clear signal that those persons, whether public or private, who would put profit before safety will not be allowed to threaten the public health.
Importation of illegal medicines is risky business. Americans should not have to choose between safe products and products that are affordable.
Congress is poised to provide access to safe and affordable drugs for all Americans through actions like a Medicare prescription drug benefit and new laws to improve access to inexpensive generic drugs. Such legislation would help millions of Americans obtain medicines that are both safe and affordable.
FDA is continuing to uphold its longstanding obligation under the law that Congress has given us -- to protect Americans from illegal drugs that may be unsafe, ineffective, poorly made, substandard or counterfeit.
####